ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

ECM2, a prognostic biomarker for lower grade glioma, serves as a potential novel target for immunotherapy

Cheng, Xingbo; Liu, Zhendong; Liang, Wenjia; Zhu, Qingyun; Wang, Chao; Wang, Hongbo; Zhang, Jiangfen; Li, Pengxu; Gao, Yanzheng*兰州大学; 哈尔滨医科大学; 郑州大学
International Journal of Biochemistry and Cell Biology2023-5DOI: 10.1016/j.biocel.2023.106409
3被引12阅读
引用收藏
分享

摘要

Extracellular matrix protein 2 (ECM2), which regulates cell proliferation and differentiation, has recently been reported as a prognostic indicator for multiple cancers, but its value in lower grade glioma (LGG) remains unknown. In this study, LGG transcriptomic data of 503 cases in The Cancer Genome Atlas (TCGA) database and 403 cases in The Chinese Glioma Genome Atlas (CGGA) database were collected to analyze ECM2 expression patterns and the relationship with clinical characteristics, prognosis, enriched signaling pathways, and immune related markers. In addition, a total of 12 laboratory samples were used for experimental validation. Wilcoxon or Kruskal-Wallis tests demonstrated highly expressed ECM2 in LGG was positively associated with malignant histological features and molecular features such as recurrent LGG and isocitrate dehydrogenase (IDH) wild-type. Also, Kaplan-Meier (KM) curves proved high ECM2 expression could predict shorter overall survival in LGG patients, as multivariate analysis and meta-analysis claimed ECM2 was a deleterious factor for LGG prognosis. In addition, the enrichment of immune-related pathways for ECM2, for instance JAK-STAT pathway, was obtained by Gene Set Enrichment Analysis (GSEA) analysis. Furthermore, positive relationships between ECM2 expression with immune cells infiltration and cancer-associated fibroblasts (CAFs), iconic markers (CD163), and immune checkpoints (CD274, encoding PD-L1) were proved by Pearson correlation analysis. Finally, laboratory experiments of RT-qPCR and immunohistochemistry showed high expression of ECM2, as well as CD163 and PD-L1 in LGG samples. This study identifies ECM2, for the first time, as a subtype marker and prognostic indicator for LGG. ECM2 could also provide a reliable guarantee for further personalized therapy, synergizing with tumor immunity, to break through the current limitations and thus reinvigorating immunotherapy for LGG. Availability of data and materials: Raw data from all public databases involved in this study are stored in the online repository (chengMD2022/ECM2 (github.com)).

学科与关键词

关键词
LGGECM2TCGAPrognosisTumor immunityCD163
相关
加载中…
  • Effects of ESCO2 or its methylation on the prognosis, clinical characteristics, immune microenvironment, and pathogenesis of low-grade glioma
    Liu, Zhendong; Cheng, Xingbo; Pang, Bo; Wang, Sen; Liu, Binfeng; Cao, Chen; Qian, Rongjun*; Liang, Wenjia; Zhu, Yongjie; Li, Pengxu; Gao, Yanzheng*International Immunopharmacology, 2022, 104: 108399.
  • CCR5 as a Prognostic Factor in Lower-Grade Glioma is Involved in the Remodeling of the Tumor Microenvironment
    Wang, Fang; Tao, Zhennan; Tian, Zhen; Jin, Jiaqi; Dong, Jiawei; Dai, Yuxiang; Yu, Wanli*; Tang, Bin*; Hu, Shaoshan*Frontiers in Genetics, 2022, 13: 874896.被引 2
  • High expression of ZFP36L2 correlates with the prognosis and immune infiltration in lower-grade glioma
    Zhou, Min*; Li, Jinquan; Chen, Cheng*Frontiers in Genetics, 2022, 13: 914219.
查看全部 →

发表信息

论文状态
公开发表
期刊
International Journal of Biochemistry and Cell Biology
发表日期
2023-05
卷期
第 158 卷
页码
106409
DOI
10.1016/j.biocel.2023.106409
语言
ENGLISH
成果收录
SCIE
资助标注
Tackling key problems of science and technology in Henan Province [222102310002, 232102311159]; Medical Science and technology research plan in Henan Province [LHGJ20210013]

作者

  • C

    Cheng, Xingbo (第一作者)

    henan prov peoples hosp · henan univ · zhengzhou univ

  • L

    Liu, Zhendong

    henan prov peoples hosp · henan univ · zhengzhou univ

查看全部 9 位作者收起作者
  • L

    Liang, Wenjia

    henan prov peoples hosp · henan univ

  • Z

    Zhu, Qingyun

    henan prov peoples hosp · henan univ

  • W

    Wang, Chao

    harbin med univ

  • W

    Wang, Hongbo

    2 · lanzhou univ

  • Z

    Zhang, Jiangfen

    henan prov peoples hosp · henan univ · zhengzhou univ

  • L

    Li, Pengxu

    henan prov peoples hosp · henan univ · zhengzhou univ

  • G

    Gao, Yanzheng (通讯)

    henan prov peoples hosp · henan univ · zhengzhou univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417